CN1138755C - 作为药物的环状氨基酸及其衍生物 - Google Patents
作为药物的环状氨基酸及其衍生物 Download PDFInfo
- Publication number
- CN1138755C CN1138755C CNB98810346XA CN98810346A CN1138755C CN 1138755 C CN1138755 C CN 1138755C CN B98810346X A CNB98810346X A CN B98810346XA CN 98810346 A CN98810346 A CN 98810346A CN 1138755 C CN1138755 C CN 1138755C
- Authority
- CN
- China
- Prior art keywords
- acetate
- amino methyl
- cyclopentyl
- methyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/50—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
- C07C205/51—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/50—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
- C07C205/53—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/385—Saturated compounds containing a keto group being part of a ring
- C07C49/417—Saturated compounds containing a keto group being part of a ring polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/608—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a ring other than a six-membered aromatic ring in the acid moiety
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/96—Spiro-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/96—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/50—Spiro compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (14)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6364497P | 1997-10-27 | 1997-10-27 | |
US60/063,644 | 1997-10-27 | ||
US9768598P | 1998-08-24 | 1998-08-24 | |
US60/097,685 | 1998-08-24 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2003101209321A Division CN1303059C (zh) | 1997-10-27 | 1998-09-23 | 作为药物的环状氨基酸及其衍生物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1276784A CN1276784A (zh) | 2000-12-13 |
CN1138755C true CN1138755C (zh) | 2004-02-18 |
Family
ID=26743626
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB98810346XA Expired - Fee Related CN1138755C (zh) | 1997-10-27 | 1998-09-23 | 作为药物的环状氨基酸及其衍生物 |
CNB2003101209321A Expired - Fee Related CN1303059C (zh) | 1997-10-27 | 1998-09-23 | 作为药物的环状氨基酸及其衍生物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2003101209321A Expired - Fee Related CN1303059C (zh) | 1997-10-27 | 1998-09-23 | 作为药物的环状氨基酸及其衍生物 |
Country Status (31)
Country | Link |
---|---|
US (3) | US6635673B1 (zh) |
EP (1) | EP1032555B1 (zh) |
JP (2) | JP3756761B2 (zh) |
KR (1) | KR100589066B1 (zh) |
CN (2) | CN1138755C (zh) |
AR (1) | AR013726A1 (zh) |
AT (1) | ATE323067T1 (zh) |
AU (1) | AU755800B2 (zh) |
BR (1) | BR9813284B1 (zh) |
CA (1) | CA2303244C (zh) |
CO (1) | CO5280097A1 (zh) |
CU (1) | CU23048A3 (zh) |
CY (1) | CY1105062T1 (zh) |
DE (1) | DE69834204T2 (zh) |
DK (1) | DK1032555T3 (zh) |
ES (1) | ES2260850T3 (zh) |
GE (1) | GEP20094817B (zh) |
HK (2) | HK1030768A1 (zh) |
HU (1) | HUP0004310A3 (zh) |
IL (1) | IL134732A (zh) |
IS (1) | IS2489B (zh) |
NO (1) | NO327671B1 (zh) |
NZ (1) | NZ503651A (zh) |
PE (1) | PE122799A1 (zh) |
PL (2) | PL199500B1 (zh) |
PT (1) | PT1032555E (zh) |
SI (1) | SI1032555T1 (zh) |
TR (1) | TR200001170T2 (zh) |
UY (1) | UY25223A1 (zh) |
WO (1) | WO1999021824A1 (zh) |
ZA (1) | ZA989740B (zh) |
Families Citing this family (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU225502B1 (en) * | 1998-12-29 | 2007-01-29 | Richter Gedeon Vegyeszet | Process for producing 1-(amino-metyl)-cyclohexene-acetic-acid and intermediates |
CA2373210A1 (en) * | 1999-05-26 | 2000-12-07 | Warner-Lambert Company | Fused polycyclic amino acids as pharmaceutical agents |
EP1192125B9 (en) * | 1999-06-10 | 2009-09-16 | Warner-Lambert Company LLC | Mono-substituted 3-propyl gamma-aminobutyric acids |
US6642398B2 (en) | 1999-06-10 | 2003-11-04 | Warner-Lambert Company | Mono-and disubstituted 3-propyl gamma-aminobutyric acids |
EP1840117A1 (en) * | 1999-06-10 | 2007-10-03 | Warner-Lambert Company LLC | Mono- and disubstituted 3-propyl gamma-aminobutyric acids |
US7164034B2 (en) | 1999-06-10 | 2007-01-16 | Pfizer Inc. | Alpha2delta ligands for fibromyalgia and other disorders |
HN2000000224A (es) | 1999-10-20 | 2001-04-11 | Warner Lambert Co | Aminoacidos biciclicos como agentes farmaceuticos |
US6864390B2 (en) | 1999-12-08 | 2005-03-08 | Warner-Lambert Company | Method for the stereoselective synthesis of cyclic amino acids |
EP1237847B1 (en) * | 1999-12-08 | 2006-05-17 | Warner-Lambert Company Llc | Method for the stereoselective synthesis of cyclic amino acids |
GB2362646A (en) * | 2000-05-26 | 2001-11-28 | Warner Lambert Co | Cyclic amino acid derivatives useful as pharmaceutical agents |
KR100785182B1 (ko) | 2000-06-26 | 2007-12-11 | 워너-램버트 캄파니 엘엘씨 | 수면 장애를 위한 가바펜틴 유사체 |
GB2364049A (en) | 2000-06-28 | 2002-01-16 | Warner Lambert Co | Cyclic ketones and their use in the synthesis of amino acids |
EP1343805A4 (en) | 2000-10-06 | 2005-07-20 | Xenoport Inc | COMPOUNDS DERIVED FROM GALLENIC ACIDS FOR THE PROVISION OF CONTINUING SYSTEMIC CONCENTRATIONS OF MEDICINAL PRODUCTS AFTER ORAL ADMINISTRATION |
EP1361847A2 (en) | 2000-10-06 | 2003-11-19 | Xenoport, Inc. | Bile-acid conjugates for providing sustained systemic concentrations of drugs |
EP1226820A1 (en) * | 2001-01-26 | 2002-07-31 | Warner-Lambert Company | Use of bicyclic amino acids for preventing and treating visceral pain and gastrointestinal disorders |
GB2374595A (en) * | 2001-04-19 | 2002-10-23 | Warner Lambert Co | Fused bicyclic or tricyclic amino acids |
PL366406A1 (en) | 2001-04-19 | 2005-01-24 | Warner-Lambert Company Llc | Fused bicyclic or tricyclic amino acids |
US7186855B2 (en) * | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
EP1412324A4 (en) | 2001-06-11 | 2004-09-29 | Xenoport Inc | AMINO ACID CONJUGATES THAT RESULT IN GABA ANALOGA LASTING SYSTEMIC CONCENTRATIONS |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
ES2296956T5 (es) | 2001-06-11 | 2011-07-12 | Xenoport, Inc. | Profármacos de análogos de gaba, composiciones y sus usos. |
AU2002316231A1 (en) | 2002-02-19 | 2003-09-29 | Xenoport, Inc. | Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof |
WO2003080588A1 (en) | 2002-03-20 | 2003-10-02 | Xenoport | Cyclic 1-(acyloxy)-alkyl prodrugs of gaba analogs, compositions and uses thereof |
WO2003099338A2 (en) | 2002-05-17 | 2003-12-04 | Xenoport, Inc. | Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
GB0223072D0 (en) | 2002-10-04 | 2002-11-13 | Pfizer Ltd | Cyclic nitromethyl acetic acid derivatives |
US7018818B2 (en) | 2002-10-04 | 2006-03-28 | Pfizer Inc. | Intermediates in the preparation of therapeutic fused bicyclic amino acids |
US7025745B2 (en) * | 2002-10-07 | 2006-04-11 | Advanced Cardiovascular Systems, Inc. | Method of making a catheter balloon using a tapered mandrel |
US7060727B2 (en) | 2002-12-11 | 2006-06-13 | Xenoport, Inc. | Prodrugs of fused GABA analogs, pharmaceutical compositions and uses thereof |
WO2004054566A1 (en) | 2002-12-13 | 2004-07-01 | Warner-Lambert Company Llc | Pregabalin derivatives for the treatment of fibromyalgia and other disorders |
DE60332387D1 (de) | 2002-12-13 | 2010-06-10 | Warner Lambert Co | Alpha-2-delta-ligand zur behandlung vonsymptomen der unteren harnwege |
JP2006511605A (ja) * | 2002-12-13 | 2006-04-06 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | 線維筋痛及び他の関連障害のためのガバペンチン類縁体 |
CA2451267A1 (en) | 2002-12-13 | 2004-06-13 | Warner-Lambert Company Llc | Pharmaceutical uses for alpha2delta ligands |
WO2005002585A1 (en) * | 2003-07-02 | 2005-01-13 | Warner-Lambert Company Llc | Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor |
KR20060119971A (ko) | 2003-09-11 | 2006-11-24 | 제노포트 인코포레이티드 | Gaba 유사체의 전구약물을 이용한 요실금의 치료및/또는 예방 |
CN1849153A (zh) | 2003-09-12 | 2006-10-18 | 辉瑞大药厂 | 含有α-2-δ配体和5-羟色胺/去甲肾上腺素重摄取抑制剂的组合物 |
CN1871021B (zh) | 2003-09-17 | 2010-07-28 | 什诺波特有限公司 | 用gaba类似物的前药治疗或预防多动腿综合征 |
SI1677767T1 (sl) | 2003-10-14 | 2011-11-30 | Xenoport Inc | Kristalinična oblika analoga gama-aminomaslene kisline |
DK1691811T3 (da) | 2003-12-11 | 2014-10-20 | Sunovion Pharmaceuticals Inc | Kombination af et sedativ og en neurotransmittermodulator og fremgangsmåder til forbedring af søvnkvaliteten og behandling af depression |
UA82292C2 (uk) * | 2004-04-14 | 2008-03-25 | Пфайзер Продактс Инк. | Спосіб стереоселективного біоперетворення аліфатичних динітрилів в ціанокарбонові кислоти (варіанти) |
BRPI0517227B8 (pt) | 2004-11-04 | 2021-05-25 | Xenoport Inc | comprimido oral de liberação prolongada do ácido 1-{[alfa-isobutanoiloxietoxi)carbonil]amino metil}-1-cicloexano acético, e, uso do comprimido |
WO2006092692A1 (en) * | 2005-03-01 | 2006-09-08 | Pfizer Limited | Use of combinations of pde7 inhibitors and alpha-2-delty ligands for the treatment of neuropathic pain |
WO2007010387A2 (en) * | 2005-07-18 | 2007-01-25 | Pharmacia & Upjohn Company Llc | Stereoselective synthesis of 3,4-disubstituted cyclopentanones and related compounds |
EP1820502A1 (en) | 2006-02-10 | 2007-08-22 | Laboratorios Del Dr. Esteve, S.A. | Active substance combination comprising azolylcarbinol compounds |
EP1993529A1 (en) * | 2006-03-06 | 2008-11-26 | Pfizer Products Inc. | Alpha-2-delta ligands for non-restorative sleep |
AR061728A1 (es) * | 2006-06-30 | 2008-09-17 | Pfizer Prod Inc | Composicion para tratamiento usando compuestos selectivos alfa-2-delta-1 |
RS51940B (en) | 2006-12-22 | 2012-02-29 | Recordati Ireland Limited | Combined TH2δ LIGANAD THERAPY AND NSAID FOR LOWER URINARY TRACT DISORDERS |
WO2008155619A2 (en) * | 2007-06-21 | 2008-12-24 | Pfizer Inc. | Preparation of optically-active cyclic amino acids |
EP2192109B1 (en) | 2007-09-28 | 2013-09-04 | Daiichi Sankyo Company, Limited | Bicyclic -amino acid derivative |
US7872046B2 (en) | 2008-01-25 | 2011-01-18 | Xenoport, Inc. | Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use |
TWI369202B (en) | 2008-01-25 | 2012-08-01 | Xenoport Inc | Enantiomerically resolving acyloxyalkyl thiocarbonates used in synthesizing acyloxyalkyl carbamate prodrugs |
US7868043B2 (en) | 2008-01-25 | 2011-01-11 | Xenoport, Inc. | Mesophasic forms of (3S)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use |
EP2116539A1 (en) | 2008-04-25 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof |
CN102216257B (zh) | 2008-10-08 | 2015-11-25 | 凯飞药业公司 | Gaba偶联物及其使用方法 |
ES2635354T3 (es) | 2009-03-26 | 2017-10-03 | Daiichi Sankyo Company, Limited | Procedimiento de producción de un derivado de ácido gamma-amino bicíclico |
EP2353598A1 (en) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for use in the prevention and/or treatment of postoperative pain |
EP2353591A1 (en) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof |
EP2388005A1 (en) | 2010-05-21 | 2011-11-23 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy |
EP2415471A1 (en) | 2010-08-03 | 2012-02-08 | Laboratorios Del. Dr. Esteve, S.A. | Use of sigma ligands in opioid-induced hyperalgesia |
EP2524694A1 (en) | 2011-05-19 | 2012-11-21 | Laboratorios Del. Dr. Esteve, S.A. | Use of sigma ligands in diabetes type-2 associated pain |
EP2719677B1 (en) | 2011-06-08 | 2017-09-06 | Daiichi Sankyo Company, Limited | Method for producing bicyclic compound via claisen rearrangement |
CN103582622B (zh) | 2011-06-08 | 2015-06-10 | 第一三共株式会社 | 经由亚胺鎓盐制备双环化合物的方法 |
WO2013089188A1 (ja) | 2011-12-15 | 2013-06-20 | 第一三共株式会社 | 不斉触媒を用いる二環性化合物の光学分割方法 |
CA2869994C (en) | 2012-04-10 | 2017-05-30 | Daiichi Sankyo Company, Limited | Optical resolution method for bicyclic compound using enzyme |
US9066853B2 (en) | 2013-01-15 | 2015-06-30 | Warsaw Orthopedic, Inc. | Clonidine compounds in a biodegradable fiber |
HUE047629T2 (hu) | 2013-01-28 | 2020-05-28 | Lopez Hector L | Eljárások ß-alanin tolerancia, farmakodinamika és hatékonyság javítására és azok alkalmazása |
TWI635071B (zh) | 2013-07-08 | 2018-09-11 | 第一三共股份有限公司 | 光學活性二環γ-胺基酸衍生物及其製造方法 |
TN2016000228A1 (en) | 2013-12-17 | 2017-10-06 | Esteve Labor Dr | SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIs) AND SIGMA RECEPTOR LIGANDS COMBINATIONS. |
TN2016000229A1 (en) | 2013-12-17 | 2017-10-06 | Esteve Labor Dr | Gabapentinoids and sigma receptor ligands combinations. |
EP4227293A3 (en) | 2018-05-14 | 2023-10-04 | Xgene Pharmaceutical Inc | Crystalline forms of 1-(acyloxy)-alkyl carbamate drug conjugates of naproxen and pregabalin |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2460891C2 (de) * | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
US4087544A (en) | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
DE2611690A1 (de) | 1976-03-19 | 1977-09-22 | Goedecke Ag | Cyclische sulfonyloxyimide |
CA1085420A (en) | 1977-03-24 | 1980-09-09 | Johannes Hartenstein | 1-aminomethyl-1-cycloalkane-acetic acid |
US5319135A (en) | 1989-08-25 | 1994-06-07 | Warner-Lambert Company | Process for cyclic amino acid anticonvulsant compounds |
DE3928184A1 (de) | 1989-08-25 | 1991-02-28 | Goedecke Ag | Verfahren zur herstellung von cyclischen aminosaeurederivaten sowie zwischenprodukte |
US5132451A (en) | 1989-08-25 | 1992-07-21 | Warner-Lambert Company | Process for cyclic amino acid anticonvulsant compounds |
US5084479A (en) | 1990-01-02 | 1992-01-28 | Warner-Lambert Company | Novel methods for treating neurodegenerative diseases |
EP0458751A1 (en) | 1990-05-25 | 1991-11-27 | Warner-Lambert Company | Delivery system for cyclic amino acids with improved taste, texture and compressibility |
US5025035A (en) | 1990-10-12 | 1991-06-18 | Warner-Lambert Company | Method of treating depression |
DE69116499T2 (de) | 1990-10-20 | 1996-08-22 | Takasago Perfumery Co Ltd | Verfahren zur Herstellung von Alpha-Hydroxyketonen |
WO1993007111A1 (en) | 1991-10-02 | 1993-04-15 | Smithkline Beecham Corporation | Cyclopentane and cyclopentene derivatives with antiallergic antiinflammatory and tumor necrosis factor inhibiting activity |
US5631291A (en) | 1992-05-29 | 1997-05-20 | Bayer Aktiengesellschaft | Cyclopentane- and -pentene-β-amino acids |
DE4400749A1 (de) | 1994-01-13 | 1995-07-20 | Bayer Ag | Neues hochenantioselektives Verfahren zur Herstellung von enantiomerenreinen Cyclopentan- und -penten-beta-Aminosäuren |
HU0102041D0 (en) | 1994-07-27 | 2001-07-30 | Warner Lambert Co | Pharmacological compounds which bind to [3h]-gabapentine binding protein |
US5510381A (en) | 1995-05-15 | 1996-04-23 | Warner-Lambert Company | Method of treatment of mania and bipolar disorder |
EP0888286B1 (en) * | 1996-03-14 | 2001-10-31 | Warner-Lambert Company | Novel substituted cyclic amino acids as pharmaceutical agents |
HRP980342A2 (en) | 1997-06-25 | 1999-02-28 | Warner Lambert Co | Anti-inflammatory method |
US9858641B2 (en) * | 2014-12-15 | 2018-01-02 | International Business Machines Corporation | Representing a system using viewpoints |
US9419648B1 (en) * | 2015-09-18 | 2016-08-16 | Intel Corporation | Supporting data compression using match scoring |
-
1998
- 1998-09-23 DE DE69834204T patent/DE69834204T2/de not_active Expired - Lifetime
- 1998-09-23 PT PT98950649T patent/PT1032555E/pt unknown
- 1998-09-23 CN CNB98810346XA patent/CN1138755C/zh not_active Expired - Fee Related
- 1998-09-23 GE GEAP199811187A patent/GEP20094817B/en unknown
- 1998-09-23 CA CA002303244A patent/CA2303244C/en not_active Expired - Fee Related
- 1998-09-23 SI SI9830831T patent/SI1032555T1/sl unknown
- 1998-09-23 BR BRPI9813284-9A patent/BR9813284B1/pt not_active IP Right Cessation
- 1998-09-23 DK DK98950649T patent/DK1032555T3/da active
- 1998-09-23 PL PL340285A patent/PL199500B1/pl not_active IP Right Cessation
- 1998-09-23 IL IL13473298A patent/IL134732A/en not_active IP Right Cessation
- 1998-09-23 TR TR2000/01170T patent/TR200001170T2/xx unknown
- 1998-09-23 ES ES98950649T patent/ES2260850T3/es not_active Expired - Lifetime
- 1998-09-23 CN CNB2003101209321A patent/CN1303059C/zh not_active Expired - Fee Related
- 1998-09-23 CU CU20000089A patent/CU23048A3/es not_active IP Right Cessation
- 1998-09-23 WO PCT/US1998/019876 patent/WO1999021824A1/en active IP Right Grant
- 1998-09-23 US US09/485,382 patent/US6635673B1/en not_active Expired - Fee Related
- 1998-09-23 AU AU96638/98A patent/AU755800B2/en not_active Ceased
- 1998-09-23 NZ NZ503651A patent/NZ503651A/xx not_active IP Right Cessation
- 1998-09-23 PL PL380277A patent/PL199794B1/pl not_active IP Right Cessation
- 1998-09-23 HU HU0004310A patent/HUP0004310A3/hu unknown
- 1998-09-23 EP EP98950649A patent/EP1032555B1/en not_active Expired - Lifetime
- 1998-09-23 AT AT98950649T patent/ATE323067T1/de active
- 1998-09-23 JP JP2000517936A patent/JP3756761B2/ja not_active Expired - Fee Related
- 1998-09-23 KR KR1020007004472A patent/KR100589066B1/ko not_active IP Right Cessation
- 1998-10-26 ZA ZA989740A patent/ZA989740B/xx unknown
- 1998-10-26 AR ARP980105348A patent/AR013726A1/es active IP Right Grant
- 1998-10-26 CO CO98062354A patent/CO5280097A1/es not_active Application Discontinuation
- 1998-10-26 UY UY25223A patent/UY25223A1/es not_active IP Right Cessation
- 1998-10-27 PE PE1998001007A patent/PE122799A1/es not_active Application Discontinuation
-
2000
- 2000-03-03 IS IS5395A patent/IS2489B/is unknown
- 2000-04-26 NO NO20002118A patent/NO327671B1/no not_active IP Right Cessation
-
2001
- 2001-03-12 HK HK01101728A patent/HK1030768A1/xx not_active IP Right Cessation
-
2003
- 2003-05-30 US US10/448,834 patent/US6921835B2/en not_active Expired - Fee Related
-
2004
- 2004-07-06 HK HK04104849A patent/HK1061841A1/xx not_active IP Right Cessation
-
2005
- 2005-03-11 US US11/078,961 patent/US7122678B2/en not_active Expired - Fee Related
- 2005-11-02 JP JP2005319009A patent/JP4263717B2/ja not_active Expired - Fee Related
-
2006
- 2006-07-03 CY CY20061100906T patent/CY1105062T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1138755C (zh) | 作为药物的环状氨基酸及其衍生物 | |
CN1165518C (zh) | 作为药学试剂的双环氨基酸类化合物 | |
CN1310872C (zh) | 单和双取代的3-丙基-γ-氨基丁酸 | |
CN1305839C (zh) | 苯基甘氨酸衍生物 | |
CN1279674A (zh) | 1-取代-1-氨基甲基-环烷衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途 | |
CN1720038A (zh) | 治疗纤维肌痛及其它病症用的加巴喷丁类似物类 | |
CN1016778B (zh) | 螺-取代的戊二酸单酰胺 | |
CN1279667A (zh) | 4(3)取代-4(3)-氨基甲基-(硫代)吡喃(噻喃)或-哌啶衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途 | |
CN1471515A (zh) | 作为β2-肾上腺素受体激动剂及PDE-4抑制剂的有效的化合物 | |
CN1218471A (zh) | 咔啉衍生物 | |
CN1077954A (zh) | 新的苯并吡喃衍生物 | |
CN1137889C (zh) | 新三环酰胺化合物,其制法和含它们的药物组合物 | |
CN1068825A (zh) | 四氢吡咯并[1,2-a]吡嗪-4-螺-3′吡咯烷衍生物的制备方法 | |
CN1105799A (zh) | 作为基质金属蛋白酶抑制剂的喹诺酮衍生物 | |
CN1068816A (zh) | 吲哚类衍生物 | |
CN1147467C (zh) | 环戊基烷基腈 | |
CN1720219A (zh) | 稠合二环或三环氨基酸 | |
CN88101674A (zh) | 色酮衍生物 | |
CN1171846C (zh) | 二萜衍生物以及包含该衍生物的消炎镇痛药 | |
CN1200729A (zh) | 用作止痛剂的旋光苯基嘧啶衍生物 | |
CN1407967A (zh) | 立体选择性地合成环状氨基酸的方法 | |
CN1192014C (zh) | Hiv蛋白酶抑制剂的制备方法 | |
CN1216856C (zh) | 具有亚环烷基链的新环状化合物,其制备方法和含有它们的药物组合物 | |
CN1064349C (zh) | 新型三环酰胺、其制备方法及其药物组合物 | |
CN1199960C (zh) | 新的沉香呋喃衍生物,它们的制备方法,含它们的药物组合物及它们作为药物的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CI01 | Publication of corrected invention patent application |
Correction item: Denomination of Invention Correct: Cyclic amino acids and derivatives thereof False: A cyclic amino acid and its organism as a drug Number: 50 Page: 121 Volume: 16 |
|
CI02 | Correction of invention patent application |
Correction item: Denomination of Invention Correct: Cyclic amino acids and derivatives thereof False: A cyclic amino acid and its organism as a drug Number: 50 Page: The title page Volume: 16 |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTION NAME; FROM: CYCLIC AMINO ACID AND LIVING BEINGS AS THE MEDICINE TO: CYCLIC AMINOACID AND DERIVANT AS THE MEDICINE |
|
ERR | Gazette correction |
Free format text: CORRECT: INVENTION NAME; FROM: CYCLIC AMINO ACID AND LIVING BEINGS AS THE MEDICINE TO: CYCLIC AMINOACID AND DERIVANT AS THE MEDICINE |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CI01 | Publication of corrected invention patent application |
Correction item: Priority Correct: 1997.10.27 US 60/063,644|1997.08.24 US 60/097,685 False: 1997.10.27 US 60/063,644 Number: 7 Page: 394 Volume: 20 |
|
CI03 | Correction of invention patent |
Correction item: Priority Correct: 1997.10.27 US 60/063,644|1997.08.24 US 60/097,685 False: 1997.10.27 US 60/063,644 Number: 7 Page: The title page Volume: 20 |
|
COR | Change of bibliographic data |
Free format text: CORRECT: PRIORITY; FROM: 1997.10.27 US 60/063,644 TO: 1997.10.27 US 60/063,644 1997.8.24 US 60/097,685 |
|
ERR | Gazette correction |
Free format text: CORRECT: PRIORITY; FROM: 1997.10.27 US 60/063,644 TO: 1997.10.27 US 60/063,644 1997.8.24 US 60/097,685 |
|
CI01 | Publication of corrected invention patent application |
Correction item: Priority Correct: 1997.10.27 US 60/063,644|1998.08.24 US 097,685 False: 1997.10.27 US 60/063,644 Number: 7 Volume: 20 |
|
CI03 | Correction of invention patent |
Correction item: Priority Correct: 1997.10.27 US 60/063,644|1998.08.24 US 097,685 False: 1997.10.27 US 60/063,644 Number: 7 Page: The title page Volume: 20 |
|
COR | Change of bibliographic data |
Free format text: CORRECT: PRIORITY; FROM: 1997.10.27 US 60/063,644 TO: 1997.10.27 US 60/063,644 1998.8.24 US 097,685 |
|
ERR | Gazette correction |
Free format text: CORRECT: PRIORITY; FROM: 1997.10.27 US 60/063,644 TO: 1997.10.27 US 60/063,644 1998.8.24 US 097,685 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1030768 Country of ref document: HK |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040218 Termination date: 20130923 |